Also, HER2 protein overexpressing tumours showed significantly higher expression of several receptor tyrosine kinases (RTKs) including FGFR4, EGFR, HER2 itself, as well as genes within the HER2 amplified region on Chr17q12-q21 (including GRB7). The gene discussed is ERBB2; the disease is neoplasm.